Evidence map›Paper›PMID 39471851›Full record

ArticleProceedings. Biological sciences2024

Adaptive human behaviour modulates the impact of immune life history and vaccination on long-term epidemic dynamics.

Baltazar Espinoza, Chadi M Saad-Roy, Bryan T Grenfell, Simon A Levin, Madhav Marathe

Abstract read
In one paragraph

Article in Proceedings. Biological sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Faster Uptake, Slower Let-Down: Asymmetric Community Responses to Changing Risks During a Pandemic.Risk analysis : an official publication of the Society for Risk Analysis · 2026
    Article
  3. Integrated framework to study genomic surveillance of selective sweeps in multivariants dynamics.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Baltazar EspinozaBiocomplexity Institute, University of Virginia, Charlottesville, VA, USA.ORCID 0000-0002-6280-3277
Chadi M Saad-RoyMiller Institute for Basic Research in Science, University of California, Berkeley, CA, USA.ORCID 0000-0002-2217-3071
Bryan T GrenfellDepartment of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA.
Simon A LevinDepartment of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA.ORCID 0000-0002-8216-5639
Madhav MaratheBiocomplexity Institute, University of Virginia, Charlottesville, VA, USA.

Funding

CDC HHS 6NU50CK000555-03-01National Science Foundation CCF-1917819National Science Foundation CCF-1918656Princeton Catalysis InitiativePrinceton Precision Health
6 · The paper itself

Abstract

The multiple immunity responses exhibited in the population and co-circulating variants documented during pandemics show a high potential to generate diverse long-term epidemiological scenarios. Transmission variability, immune uncertainties and human behaviour are crucial features for the predictability and implementation of effective mitigation strategies. Nonetheless, the effects of individual health incentives on disease dynamics are not well understood. We use a behavioural-immuno-epidemiological model to study the joint evolution of human behaviour and epidemic dynamics for different immunity scenarios. Our results reveal a trade-off between the individuals' immunity levels and the behavioural responses produced. We find that adaptive human behaviour can avoid dynamical resonance by avoiding large outbreaks, producing subsequent uniform outbreaks. Our forward-looking behaviour model shows an optimal planning horizon that minimizes the epidemic burden by balancing the individual risk-benefit trade-off. We find that adaptive human behaviour can compensate for differential immunity levels, equalizing the epidemic dynamics for scenarios with diverse underlying immunity landscapes. Our model can adequately capture complex empirical behavioural dynamics observed during pandemics. We tested our model for different US states during the COVID-19 pandemic. Finally, we explored extensions of our modelling framework that incorporate the effects of lockdowns, the emergence of a novel variant, prosocial attitudes and pandemic fatigue.

Indexed as

COVID-19SARS-CoV-2VaccinationEpidemicsEpidemiological ModelsHumansPandemicsadaptive behaviourepidemic modellingimmune life historymulti-scale modeling

Identifiers

PMID39471851
PMCPMC11521615

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.